Golden State Wealth Management LLC purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 145 shares of the semiconductor company’s stock, valued at approximately $70,000.
A number of other large investors have also recently modified their holdings of the company. Kieckhefer Group LLC purchased a new stake in Synopsys in the fourth quarter worth about $27,000. Tsfg LLC lifted its position in shares of Synopsys by 75.0% in the 3rd quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 24 shares during the period. Hazlett Burt & Watson Inc. lifted its position in shares of Synopsys by 40.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares during the period. Princeton Global Asset Management LLC bought a new position in shares of Synopsys during the third quarter valued at approximately $44,000. Finally, nVerses Capital LLC purchased a new position in Synopsys during the third quarter valued at approximately $51,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on SNPS shares. Wells Fargo & Company cut their price target on Synopsys from $570.00 to $540.00 and set an “equal weight” rating on the stock in a report on Monday, January 13th. Rosenblatt Securities reiterated a “buy” rating and issued a $635.00 target price on shares of Synopsys in a research note on Wednesday, December 4th. Needham & Company LLC reissued a “buy” rating and set a $640.00 price target on shares of Synopsys in a research report on Thursday, December 5th. Redburn Atlantic started coverage on shares of Synopsys in a report on Monday, January 13th. They issued a “buy” rating and a $600.00 price target on the stock. Finally, Mizuho began coverage on shares of Synopsys in a research note on Tuesday, October 22nd. They set an “outperform” rating and a $650.00 price objective for the company. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $641.82.
Synopsys Stock Performance
Synopsys stock opened at $531.33 on Tuesday. The business’s 50-day simple moving average is $513.49 and its two-hundred day simple moving average is $518.39. The company has a market cap of $82.13 billion, a PE ratio of 36.59, a PEG ratio of 3.49 and a beta of 1.12. Synopsys, Inc. has a fifty-two week low of $457.52 and a fifty-two week high of $629.38.
Insider Buying and Selling at Synopsys
In related news, CRO Richard S. Mahoney sold 20,838 shares of the business’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the sale, the executive now owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.66% of the stock is currently owned by corporate insiders.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Compound Interest and Why It Matters When Investing
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.